MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-κB pathway and down-regulating NLRC4 inflammasome
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306137 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Wenyu Dong und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Rehabilitation Hospital, Chongqing Medical University, Chongqing, P. R. China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, NF-kappa B, Inflammasomes, Rats, Inbred SHR. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Municipal Science and Technology Bureau, Chongqing Municipal Education Commission.
Abstract (Originalsprache)
Background
Hypertensive nephropathy (HN) is one of the main causes of end-stage renal disease (ESRD), leading to serious morbidity and mortality in hypertensive patients. However, existing treatment for hypertensive nephropathy are still very limited. It has been demonstrated that aerobic exercise has beneficial effects on the treatment of hypertension. However, the underlying mechanisms of exercise in HN remain unclear.
Methods
The spontaneously hypertensive rats (SHR) were trained for 8 weeks on a treadmill with different exercise prescriptions. We detected the effects of moderate intensity continuous training (MICT) and high intensity interval training (HIIT) on inflammatory response, renal function, and renal fibrosis in SHR. We further investigated the relationship between TLR4 and the NLRC4 inflammasome in vitro HN model.
Results
MICT improved renal fibrosis and renal injury, attenuating the inflammatory response by inhibiting TLR4/NF-κB pathway and the activation of NLRC4 inflammasome. However, these changes were not observed in the HIIT group. Additionally, repression of TLR4/NF-κB pathway by TAK-242 inhibited activation of NLRC4 inflammasome and alleviated the fibrosis in Ang II-induced HK-2 cells.
Conclusion
MICT ameliorated renal damage, inflammatory response, and renal fibrosis via repressing TLR4/NF-κB pathway and the activation of NLRC4 inflammasome. This study might provide new references for exercise prescriptions of hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Affiliated Rehabilitation Hospital, Chongqing Medical University, Chongqing, P. R. China.
- Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P. R. China.
- The College of Exercise Medicine, Chongqing Medical University, Chongqing, P. R. China.
ORCID-Profile: Wenyu Dong
Förderung
- Chongqing Municipal Science and Technology Bureau
- Chongqing Municipal Education Commission
Zitieren
APA
Dong, W., Luo, M., Li, Y., Chen, X., Li, L., & Chang, Q. (2024). MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-κB pathway and down-regulating NLRC4 inflammasome. PLOS ONE. https://doi.org/10.1371/journal.pone.0306137
Vancouver
Dong W, Luo M, Li Y, Chen X, Li L, Chang Q. MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-κB pathway and down-regulating NLRC4 inflammasome. PLOS ONE. 2024. doi:10.1371/journal.pone.0306137
BibTeX
@article{Dong2024,
author = {Dong, Wenyu and Luo, Minghao and Li, Yun and Chen, Xinhua and Li, Lingang and Chang, Qing},
title = {MICT ameliorates hypertensive nephropathy by inhibiting TLR4/NF-κB pathway and down-regulating NLRC4 inflammasome},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306137}
}
EUVIMED